Kanpecia Biotech

Manufacturing · Kansas, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

2029 Melanie Cheung, Lawrence, Kansas, 6...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Kanpecia Biotech

Kanpecia is a startup emerging from the University of Kansas, focused on developing a topical medication, KaB-103, for treating chemotherapy-induced alopecia and androgenic alopecia. The innovative formula is designed for safe and painless scalp application, aiming to enhance hair regrowth and prevent hair loss in chemotherapy patients. Early studies have demonstrated promising results in hair growth compared to existing treatments, with a favorable safety profile. The company holds multiple patents for its technology and is led by a team of experienced professionals in dermatology, pharmacology, and drug delivery.Explore more
Kanpecia Biotech's Social MediaPopular SearchesKanpecia Biotech LLCKanpeciaSIC Code 28,283NAICS Code 32,325Show more

Kanpecia Biotech Org Chart

PhoneEmail
Chad Groer, Chief Operating Officer at Kanpecia Biotech
United States flag for contact location.

Chief Operating Officer

PhoneEmail
DA
United States flag for contact location.

President

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
MC
United States flag for contact location.

Lab Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Kanpecia Biotech your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Kanpecia Biotech

Compare insights from companies similar to Kanpecia Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Kanpecia Biotech

<$5M
11-50
Private
-
2020
Chad Groer, Chief Operating Officer at Kanpecia Biotech
Chad GroerChief Operating Officer
<$5M
11-50
Private
-
2010
AB
Alper BaharOffice Representative (Israel)
<$5M
11-50
Private
-
2011
JP
Jessica PaoDirector, Clinical Services
<$5M
1-10
Private
-
2014
SS
Stephine SurgeonNursing Manager
<$5M
1-10
Private
-
2002
Dave Stringham, Owner and President at Referral Experts
Dave StringhamOwner and President
<$5M
11-50
Private
-
2009
N/A
<$5M
1-10
Private
-
2011
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Kanpecia Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Kanpecia Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kanpecia Biotech.

Kanpecia Biotech Tech Stack

A closer look at the technologies used by Kanpecia Biotech

Top Manufacturing Companies

Frequently Asked Questions Regarding Kanpecia Biotech

What is Kanpecia Biotech's official website?
Kanpecia Biotech's official website is www.kanpecia.com
What is Kanpecia Biotech's Revenue?
Kanpecia Biotech's revenue is <$5 Million
What is Kanpecia Biotech's SIC code?
Kanpecia Biotech's SIC: 28,283
What is Kanpecia Biotech's NAICS code?
Kanpecia Biotech's NAICS: 32,325
How many employees does Kanpecia Biotech have?
Kanpecia Biotech has 11-50 employees
What industry does Kanpecia Biotech belong to?
Kanpecia Biotech is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Kanpecia Biotech competition?
Kanpecia Biotech top competitors include: Sound Plastic Surgery, Medspa Cosmetic & Plastic Surgery Clinic, Nima Plastic Surgery, Esteworld Turkey
What technology does Kanpecia Biotech use?
Some of the popular technologies that Kanpecia Biotech uses are: WordPress.org, PHP, Google Workspace, Gmail
What does Kanpecia Biotech do?

Kanpecia is a startup emerging from the University of Kansas, focused on developing a topical medication, KaB-103, for treating chemotherapy-induced alopecia and androgenic alopecia. The innovative formula is designed for safe and painless scalp application, aiming to enhance hair regrowth and prevent hair loss in chemotherapy patients. Early studi... es have demonstrated promising results in hair growth compared to existing treatments, with a favorable safety profile. The company holds multiple patents for its technology and is led by a team of experienced professionals in dermatology, pharmacology, and drug delivery.Read More

What are Kanpecia Biotech social media links?
Kanpecia Biotech Linkedin page
Is Kanpecia Biotech a public company?
Kanpecia Biotech is private company therefore does not currently have an official ticker symbol
See more information about Kanpecia Biotech

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.